• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.

作者信息

Venditti J M

出版信息

Cancer Treat Rep. 1983 Sep;67(9):767-72.

PMID:6883352
Abstract
摘要

相似文献

1
The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.美国国立癌症研究所抗肿瘤药物发现计划：现状与未来展望——一篇评论
Cancer Treat Rep. 1983 Sep;67(9):767-72.
2
Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy.
Cancer Treat Rep. 1983 Sep;67(9):753-65.
3
The preclinical new drug research program of the National Cancer Institute.美国国立癌症研究所的临床前新药研究项目。
Cancer Treat Rep. 1984 Jan;68(1):63-76.
4
[Models and methods used for the selection of antitumor preparations in the USSR and abroad].
Vopr Onkol. 1976;22(4):82-96.
5
Screening at the National Cancer Institute.
Natl Cancer Inst Monogr. 1977 Mar(45):37-48.
6
The discovery and development of new antileukemic drugs.新型抗白血病药物的发现与研发。
Hematol Oncol Clin North Am. 1993 Feb;7(1):233-54.
7
Clinical development of anticancer agents--a National Cancer Institute perspective.抗癌药物的临床开发——美国国立癌症研究所的观点
Cancer Treat Rep. 1984 Jan;68(1):77-85.
8
[Introduction of new screening system in National Cancer Institute].
Gan To Kagaku Ryoho. 1984 May;11(5):1134-9.
9
Modified protocol for the testing of new synthetics in the L1210 lymphoid leukemia murine model in the DR&D program, DCT, NCI.美国国立癌症研究所药物研发与开发部（DCT）针对L1210淋巴白血病小鼠模型中新型合成物测试的改良方案。
Natl Cancer Inst Monogr. 1977 Mar(45):151-3.
10
The linear array.线性阵列。
Natl Cancer Inst Monogr. 1977 Mar(45):13-4.

引用本文的文献

1
Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal Medicine.癌症化疗的精准或个性化医疗：草药医学能发挥作用吗？
Molecules. 2016 Jul 7;21(7):889. doi: 10.3390/molecules21070889.
2
Cytotoxicity Evaluation of Mycotoxins by an MTT-Bioassay.用 MTT 生物测定法评估真菌毒素的细胞毒性。
Mycotoxin Res. 1987 Sep;3(2):85-96. doi: 10.1007/BF03191994.
3
Anti-tumor effect of chemically synthesized sulfolipids based on sea urchin's natural sulfonoquinovosylmonoacylglycerols.基于海胆天然磺基喹喔啉单酰甘油的化学合成硫脂的抗肿瘤作用
Jpn J Cancer Res. 2002 Jan;93(1):85-92. doi: 10.1111/j.1349-7006.2002.tb01204.x.
4
In vivo anti-tumour effect of 3'-sulphonoquinovosyl 1'-monoacylglyceride isolated from sea urchin (Strongylocentrotus intermedius) intestine.从海胆（中间球海胆）肠道中分离出的3'-磺基喹诺糖基1'-单酰甘油的体内抗肿瘤作用。
Br J Cancer. 1997;75(3):324-32. doi: 10.1038/bjc.1997.54.
5
Effect of cisplatin on primary tumour growth and liver metastases in the M 5076 reticulum sarcoma: implication for new screening modalities.顺铂对M 5076网状细胞肉瘤原发肿瘤生长及肝转移的影响：对新筛查方式的启示
J Cancer Res Clin Oncol. 1993;119(6):312-4. doi: 10.1007/BF01208835.
6
Predictive testing in cancer chemotherapy. I. In vivo.
Pharm Weekbl Sci. 1985 Jun 21;7(3):93-9. doi: 10.1007/BF01968709.
7
Comparison of immunomodulatory and immunotherapeutic properties of biologic response modifiers.生物反应调节剂的免疫调节和免疫治疗特性比较
Springer Semin Immunopathol. 1985;8(4):429-43. doi: 10.1007/BF01857395.
8
In vitro and in vivo chemotherapy screening of the divalent cation chelator 1,10-orthophenanthroline.二价阳离子螯合剂1,10-邻菲啰啉的体外和体内化疗筛选
Cancer Chemother Pharmacol. 1985;15(1):6-10. doi: 10.1007/BF00257285.
9
Rapid chemosensitivity testing of human lung tumor cells using the MTT assay.使用MTT法对人肺肿瘤细胞进行快速化学敏感性测试。
Cancer Chemother Pharmacol. 1986;17(3):259-63. doi: 10.1007/BF00256695.
10
Activity and distribution studies of etoposide and mitozolomide in vivo and in vitro against human choriocarcinoma cell lines.
Cancer Chemother Pharmacol. 1987;19(3):221-5. doi: 10.1007/BF00252976.